Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats

FASEB Journal

Volumn 27, Issue 10, 2013, Pages 4076-4088

  Zhao, Hailin ^a   Yoshida, Akira ^a   Xiao, Wei ^a,b   Ologunde, Rele ^a   O'Dea, Kieran P ^a   Takata, Masao ^a   Tralau Stewart, Catherine ^c   George, Andrew J T ^d   Ma, Daqing ^a  

^a Department of Surgery and Cancer Section of Anaesthetics Pain Medicine and Intensive Care Faculty of Medicine ^*  (United Kingdom)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Acute rejection; Renoprotection

Indexed keywords

CYCLOSPORIN A; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; NITROGEN; XENON; CYCLOSPORIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL INFILTRATION; CELL SURVIVAL; CELL VIABILITY; COLD ISCHEMIA; CRYOPRESERVATION; DELAYED GRAFT FUNCTION; DONOR; FIBROBLAST; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY ALLOGRAFT; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; KIDNEY TUBULE CELL; MACROPHAGE; MALE; NECROSIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REOXYGENATION; REPERFUSION INJURY; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL LINE; COLD; GENE; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; LABORATORY DIAGNOSIS; LEWIS RAT; METABOLISM; PATHOLOGY; PHYSIOLOGY;

RATTUS;

ANIMALS; CELL LINE; COLD TEMPERATURE; CYCLOSPORINE; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HEME OXYGENASE-1; HSP70 HEAT-SHOCK PROTEINS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; NF-KAPPA B; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SPECIMEN HANDLING; XENON;

EID: 84885155559     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-232173     Document Type: Article

References (40)

1. Moeller, S., Gioberge, S., and Brown, G. (2002) ESRD patients in 2001: global overview of patients, treatment modalities and development trends. Nephrol. Dial. Transplant. 17, 2071-2076
2. Tantravahi, J., Womer, K. L., and Kaplan, B. (2007) Why hasn't eliminating acute rejection improved graft survival? Annu. Rev. Med. 58, 369-385
3. Meier-Kriesche, H. U., Schold, J. D., Srinivas, T. R., and Kaplan, B. (2004) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant. 4, 378-383
4. Li, C, and Yang, C. W. (2009) The pathogenesis and treatment of chronic allograft nephropathy. Nat. Rev. Nephrol. 5, 513-519
5. Jevnikar, A. M., and Mannon, R. B. (2008) Late kidney allograft loss: what we know about it, and what we can do about it. Clin. J. Am. Soc. Nephrol. 3(Suppl. 2), S56-S67
6. Siedlecki, A., Irish, W., and Brennan, D. C. (2011) Delayed graft function in the kidney transplant. Am. J. Transplant. 11, 2279-2296
7. Perico, N., Cattaneo, D., Sayegh, M. H., and Remuzzi, G. (2004) Delayed graft function in kidney transplantation. Lancet 364, 1814-1827
8. Cornell, L. D., Smith, R. N., and Colvin, R. B. (2008) Kidney transplantation: mechanisms of rejection and acceptance. Annu. Rev. Pathol. 3, 189-220
9. Mikhalski, D., Wissing, K. M., Ghisdal, L., Broeders, N., Hoang, A. D., Loi, P., Mboti, F., Donckier, V., Vereerstraeten, P., and Abramowicz, D. (2008) Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 85, S3-S9
10. Asderakis, A., Dyer, P., Augustine, T., Worthington, J., and Johnson, R. W. (2001) Effect of cold ischemic time and HLA matching in kidneys coming from "young" and "old" donors: do not leave for tomorrow what you can do tonight. Transplantation 72, 674-678
11. Lu, C. Y., Penfield, J. G., Kielar, M. L., Vazquez, M. A., and Jeyarajah, D. R. (1999) Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int. 55, 2157-2168
12. Hariharan, S., McBride, M. A., Cherikh, W. S., Tolleris, C. B., and Johnson, C. P. (2002) Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int. 62, 311-318
13. Lachmann, B., Armbruster, S., Schairer, W., Landstra, M., Van Daal, G. J., Kusuma, A., and Erdmann, W. (1990) Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet 335, 1413-1415
14. Dickinson, R., and Franks, N. P. (2010) Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit. Care 14, 229
15. Pagel, P. S. (2010) Cardioprotection by noble gases. J. Cardiothorac. Vasc. Anesth. 24, 143-163
16. Ma, D., Hossain, M., Chow, A., Arshad, M., Sanders, R. D., Mehmet, H., Edwards, A. D., Franks, N. P., and Maze, M. (2005) Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann. Neurol. 58, 182-193
17. Ma, D., Hossain, M., Pettet, G. K., Luo, Y., Akimov, S., Sanders, R. D., Franks, N. P., and Maze, M. (2006) Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J. Cereb. Blood Flow Metab. 26, 199-208
18. Ma, D., Wilhelm, S., Maze, M., and Franks, N. P. (2002) Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br. J. Anaesth. 89, 739-746
19. Ma, D., Lim, T., Xu, J., Tang, H., Zhao, H., Hossain, M., Maxwell, P. H., and Maze, M. (2009) Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J. Am. Soc. Nephrol. 20, 713-720
20. Kumar, S., Allen, D. A., Kieswich, J. E., Patel, N. S., Mazzon, E., Cuzzocrea, S., Raftery, M. J., Thiemermann, C., and Yaqoob, M. M. (2009) Dexamethasone ameliorates renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 20, 2412-2425
21. Bilolo, K. K., Ouyang, J., Wang, X., Zhu, S., Qi, S., Xu, D., Hebert, M. J., Bekersky, I., Fitzsimmons, W. E., and Chen, H. (2003) Synergistic effects of malononitrilamides (FK 778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. Transplantation 75, 1881-1887
22. Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., Furness, P., Gaber, L. W., Gibson, I. W., Glotz, D., Goldberg, J. C., Grande, J., Halloran, P. F., Hansen, H. E., Hartley, B., Hayry, P. J., Hill, C. M., Hoffman, E. O., Hunsicker, L. G., Lindblad, A. S., Marcussen, N., Mihatsch, M. J., Nadasdy, T., Nickerson, P., Olsen, T. S., Papadimitriou, J. C., Randhawa, P. S., Rayner, D. C., Roberts, I., Rose, S., Rush, D., Salinas-Madrigal, L., Salomon, D. R., Sund, S., Taskinen, E., Trpkov, K. and Yamaguchi, Y. (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int. 55, 713-723
23. Eltzschig, H. K., and Eckle, T. (2011) Ischemia and reperfusion-from mechanism to translation. Nat. Med. 17, 1391-1401
24. Jurewicz, M., Takakura, A., Augello, A., Naini, S. M., Zandi-Nejad, K., and Abdi, R. (2010) Ischemic injury enhances dendritic cell immunogenicity via TLR4 and NF-kappa B activation. J. Immunol. 184, 2939-2948
25. Wu, H., Ma, J., Wang, P., Corpuz, T. M., Wyburn, K. R., and Chadban, S. J. (2010) HMGB1 contributes to kidney ischemia reperfusion injury. J. Am. Soc. Nephrol. 21, 1878-1890
26. Kruger, B., Krick, S., Dhillon, N., Lerner, S. M., Bromberg, J. S., Lin, M., Walsh, L., Vella, J., Fischereder, M., Kramer, B. K., Colvin, R. B., Heeger, P. S., Murphy, B. T., and Schroppel, B. (2009) Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. U. S. A. 106, 3390-3395
27. Wu, H., Chen, G., Wyburn, K. R., Yin, J., Eris, J. M., Alexander, S. I., Sharland, A. F., and Chadban, S. J. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847-2859
28. Gozzelino, R., Jeney, V., and Soares, M. P. (2010) Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 50, 323-354
29. Sheikh, S. Z., Hegazi, R. A., Kobayashi, T., Onyiah, J. C., Matsuoka, K., Sepulveda, A. R., Li, F., Otterbein, L. E., and Plevy, S. E. (2011) An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J. Immunol. 186, 5506-5513
30. Willis, D., Moore, A. R., Frederick, R., and Willoughby, D. A. (1996) Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2, 87-90
31. Blydt-Hansen, T. D., Katori, M., Lassman, C., Ke, B., Iyer, S., Buelow, R., Ettenger, R., Busuttil, R. W., and Kupiec-Weglinski, J. W. (2003) Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J. Am. Soc. Nephrol. 14, 745-754
32. Mayer, M. P., and Bukau, B. (2005) Hsp70 chaperones: cellular functions and molecular mechanism. Cell. Mol. Life Sci. 62, 670-684
33. Giffard, R. G., and Yenari, M. A. (2004) Many mechanisms for hsp70 protection from cerebral ischemia. J. Neurosurg. Anesthesiol. 16, 53-61
34. Lepore, D. A., Knight, K. R., Anderson, R. L., and Morrison, W. A. (2001) Role of priming stresses and Hsp70 in protection from ischemia-reperfusion injury in cardiac and skeletal muscle. Cell Stress Chaperones 6, 93-96
35. Kuboki, S., Schuster, R., Blanchard, J., Pritts, T. A., and Lentsch, A. B. (2007) Role of heat shock protein 70 in hepatic ischemia-reperfusion injury in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1141-G1149
36. Sanders, R. D., Ma, D., and Maze, M. (2004) Xenon: elemental anaesthesia in clinical practice. Br. Med. Bull. 71, 115-135
37. Lynch, C., 3rd, Baum, J., and Tenbrinck, R. (2000) Xenon anesthesia. Anesthesiology 92, 865-868
38. Abraini, J. H., David, H. N., and Lemaire, M. (2005) Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann. N. Y. Acad. Sci. 1053, 289-300
39. Lockwood, G. G., Franks, N. P., Downie, N. A., Taylor, K. M., and Maze, M. (2006) Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass: phase I study. Anesthesiology 104, 458-465
40. Rawat, S., and Dingley, J. (2010) Closed-circuit xenon delivery using a standard anesthesia workstation. Anesth. Analg. 110, 101-109